Fritcet TZ 1.125 Injection

Composition : Ceftriaxone Sodium I.P. 1000mg + Tazobactam Sodium I.P. 125mg

Dosage Form : Injection

Packaging Type : Vial + Water

Packaging : Mono

Price : ₹199/-

Please Contact For Best Price

Fritcet TZ 1.125 Injection is a potent combination antibiotic that merges the efficacy of Ceftriaxone, a third-generation cephalosporin, with Tazobactam, a beta-lactamase inhibitor. This combination is specifically designed to combat severe bacterial infections caused by beta-lactamase-producing organisms that are resistant to conventional antibiotics.

Ceftriaxone works by inhibiting bacterial cell wall synthesis, leading to bacterial cell death, while Tazobactam enhances its activity by neutralizing the resistance mechanisms of beta-lactamase enzymes. This dual-action makes the injection highly effective against a broad spectrum of Gram-positive and Gram-negative bacteria.

Fritcet TZ is widely prescribed for treating complicated intra-abdominal infections, skin and soft tissue infections, respiratory tract infections, urinary tract infections, and septicemia. It is also beneficial in cases where other antibiotics fail due to resistance.

Read More

About the Product

Fritcet TZ 1.125 Injection is a potent combination antibiotic that merges the efficacy of Ceftriaxone, a third-generation cephalosporin, with Tazobactam, a beta-lactamase inhibitor. This combination is specifically designed to combat severe bacterial infections caused by beta-lactamase-producing organisms that are resistant to conventional antibiotics.

Ceftriaxone works by inhibiting bacterial cell wall synthesis, leading to bacterial cell death, while Tazobactam enhances its activity by neutralizing the resistance mechanisms of beta-lactamase enzymes. This dual-action makes the injection highly effective against a broad spectrum of Gram-positive and Gram-negative bacteria.

Fritcet TZ is widely prescribed for treating complicated intra-abdominal infections, skin and soft tissue infections, respiratory tract infections, urinary tract infections, and septicemia. It is also beneficial in cases where other antibiotics fail due to resistance.

Common side effects may include diarrhea, rash, and changes in liver function tests. Severe allergic reactions and Clostridium difficile-associated diarrhea have been reported.

Used to treat severe bacterial infections, including those caused by beta-lactamase-producing organisms.

Consult a healthcare professional before use. Administer only under medical supervision, particularly in cases of renal impairment or known allergies to beta-lactam antibiotics. Fritcet TZ 1.125 Injection is an important therapeutic option in combating bacterial infections. Its dual-action mechanism not only helps to control infection effectively but also addresses the challenge of antibiotic resistance. Always adhere to prescribed dosages and treatment duration to optimize the therapeutic benefits while minimizing potential adverse effects. Regular monitoring during treatment is advised to detect any side effects early, ensuring patient safety and effective management of the infection.

Get in Touch